The fibronectin-1 pathway represents another matrix remodeling finding previously observed in smoking [52] with implications in pulmonary fibrosis [53,54], epithelial mesenchymal transition (EMT) and COPD [55,56]. Here, FN1 is linked to chronic obstructive pulmonary disease.